| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. | Br J Pharmacol | 2007 | 0.91 |
| 2 | CB1 receptor antagonism/inverse agonism increases motor system excitability in humans. | Eur Neuropsychopharmacol | 2011 | 0.75 |